Chinese Journal of Stroke ›› 2022, Vol. 17 ›› Issue (05): 455-460.DOI: 10.3969/j.issn.1673-5765.2022.05.003
Previous Articles Next Articles
Received:
2021-12-06
Online:
2022-05-20
Published:
2022-05-20
刘永辉, 杨侃, 覃福斌, 陈雯雯, 何婷婷, 黄雅帝
通讯作者:
刘永辉 liuyonghui626@126.com
基金资助:
LIU Yonghui, YANG Kan, QIN Fubin, CHEN Wenwen, HE Tingting, HUANG Yadi. Progress of Headache due to Reversible Cerebral Vasoconstriction Syndrome[J]. Chinese Journal of Stroke, 2022, 17(05): 455-460.
刘永辉, 杨侃, 覃福斌, 陈雯雯, 何婷婷, 黄雅帝. 缘于可逆性脑血管收缩综合征的头痛研究进展[J]. 中国卒中杂志, 2022, 17(05): 455-460.
[1] CALABRESE L H,DODICK D W,SCHWEDT T J,et al. Narrative review:reversible cerebral vasoconstriction syndromes[J]. Ann Intern Med,2007,146(1):34-44. [2] Hea d ache Cla ssif icat ion Com m it tee of t he International Headache Society(IHS)T he International Classification of Headache Disorders,3rd edition[J]. Cephalalgia,2018,38(1):1-211. [3] GRUNDT B,BOLLING T,RITCH M L. Reversible cerebral vasoconstriction syndrome:a common occurrence but rare diagnosis[J/OL]. Cureus,2020,12(6):e8546[2021-12-04]. https://doi.org/10.7759/cureus.8546. [4] SINGHAL A B,TOPCUOGLU M A,FOK J W,et al. Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system:clinical,imaging,and angiographic comparison[J]. Ann Neurol,2016,79(6):882-894. [5] MILLER T R,SHIVASHANKAR R,MOSSABASHA M,e t a l . R e v e r s i b l e c e r e b r a l vasoconstriction syndrome,part 1:epidemiology,pathogenesis,and clinical course[J]. AJNR Am J Neuroradiol,2015,36(8):1392-1399. [6] COFFINO S W,FRYER R H. Reversible cerebral vasoconstriction syndrome in pediatrics:a case series and review[J]. J Child Neurol,2017,32(7):614-623. [7] KIM T,AHN S,SOHN C H,et al. Reversible cerebral vasoconstriction syndrome at the emergency department[J]. Clin Exp Emerg Med,2015,2(4):203-209. [8] LING Y H,WANG Y F,LIRNG J F,et al. Postreversible cerebral vasoconstriction syndrome headache[J/OL]. J Headache Pain,2021,22(1):14[2021-12-04]. https://doi.org/10.1186/s10194-021-01223-9. [9] DUCROS A. Reversible cerebral vasoconstriction syndrome [J]. Lancet Neurol,2012,11(10):906-917. [10] TAKEMARU M,TAKESHIMA S,HARA N,et al. Reversible cerebral vasoconstriction syndrome:a clinical study of 11 cases[J]. Rinsho Shinkeigaku,2018,58(6):377-384. [11] 陈越,周仁兰. 可逆性脑血管收缩综合征的诊治进展[J]. 中风与神经疾病杂志,2019,36(5):460-463. [12] ARRIGAN M T,HERAN M K S,SHEWCHUK J R. Reversible cerebral vasoconstriction syndrome:an important and common cause of thunderclap and recurrent headaches[J]. Clin Radiol,2018,73(5):417-427. [13] TAKATA T,KUME K,KOKUDO Y,et al. Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome,accompanied by prolonged vasoconstriction [J]. Intern Med,2017,56(6):713-717. [14] JAMALI S A,ROZEN T D. An RCVS spectrum disorder? New daily persistent headache starting as a single thunderclap headache(3 new cases)[J]. Headache,2019,59(5):789-794. [15] YEBOAH K,BITTAR J,ALMAJALI M,et al. Transfusion-related acute brain injury:a case report on reversible cerebral vasoconstriction syndrome [J/OL]. Cureus,2020,12(7):e9077[2021-12-04]. https://doi.org/10.7759/cureus.9077. [16] MADHOK J,KLOOSTERBOER A,VENKATASUBRAMANIAN C,et al. Catecholamine-induced cerebral vasospasm and multifocal infarctions in pheochromocytoma[J/OL]. Endocrinol Diabetes Metab Case Rep,2020,2020:20-0078[2021-12-04]. https://doi.org/10.1530/EDM-20-0078. [17] CHEN S P,FUH J L,LIRNG J F,et al. Recurrence of reversible cerebral vasoconstriction syndrome:a long-term follow-up study[J]. Neurology,2015,84(15):1552-1558. [18] KATO Y,HAYASHI T,MIZUNO S,et al. Triptaninduced reversible cerebral vasoconstriction syndrome:two case reports with a literature review[J]. Intern Med,2016,55(23):3525-3528. [19] KATO Y,HAYASHI T,SANO H,et al. Cough headache presenting with reversible cerebral vasoconstriction syndrome[J]. Intern Med,2018,57(10):1459-1461. [20] TOPCUOGLU M A,CHAN S T,SILVA G S,et al. Cerebral vasomotor reactivity in reversible cerebral vasoconstriction syndrome[J]. Cephalalgia,2017,37(6):541-547. [21] CHEN S P,FUH J L,WANG S J. Reversible cerebral vasoconstriction syndrome:current and future perspectives[J]. Expert Rev Neurother,2011,11(9):1265-1276. [22] CAPPELEN-SMITH C,CALIC Z,CORDATO D. Reversible cerebral vasoconstriction syndrome:recognition and treatment[J/OL]. Curr Treat Options Neurol,2017,19(6):21[2021-12-04]. https://doi. org/10.1007/s11940-017-0460-7. [23] SHEIKH H U,MATHEW P G. Reversible cerebral vasoconstriction syndrome:updates and new perspectives[J/OL]. Curr Pain Headache Rep,2014,18(5):414[2021-12-04]. https://doi.org/10.1007/s11916-014-0414-7. [24] SANTOS L,AZEVEDO E. Reversible cerebral vasoconstriction syndrome-a narrative revision of the literature[J]. Porto Biomed J,2016,1(2):65-71. [25] VERMA S,BUCHANAN M R,ANDERSON T J. Endothelial function testing as a biomarker of vascular disease[J]. Circulation,2003,108(17):2054-2059. [26] CHEN S P,WANG Y F,HUANG P H,et al. Reduced circulating endothelial progenitor cells in reversible cerebral vasoconstriction syndrome[J]. J Headache Pain,2014,15(1):82[2021-12-04]. https://doi.org/10.1186/1129-2377-15-82. [27] CHOI H A,LEE M J,CHUNG C S. Cerebral endothelial dysfunction in reversible cerebral vasoconstriction syndrome:a case-control study[J/OL]. J Headache Pain,2017,18(1):29[2021-12-04]. https://doi.org/10.1186/s10194-017-0738-x. [28] JOHN S,HAJJ-ALI R A,MIN D,et al. Reversible cerebral vasoconstriction syndrome:is it more than just cerebral vasoconstriction?[J]. Cephalalgia,2015,35(7):631-634. [29] MILLER T R,SHIVASHANKAR R,MOSSABASHA M,et al. Reversible cerebral vasoconstriction syndrome,part 2:diagnostic work-up,imaging evaluation,and differential diagnosis[J]. AJNR Am J Neuroradiol,2015,36(9):1580-1588. [30] CHEN S P,FUH J L,WANG S J,et al. Brainder ived neu rot rophic factor gene Val66Met polymor phism modulates reversible cerebral vasoconstriction syndromes[J/OL]. PLoS One,2011,6(3):e18024[2021-12-04]. https://doi.org/10.1371/journal.pone.0018024. [31] D E B - C H A T T E R J I M ,SCHUSTER S ,HAEUSSLER V,et al. Primary angiitis of the central nervous system:new potential imaging techniques and biomarkers in blood and cerebrospinal fluid[J/OL]. Front Neurol,2019,10:568[2021-12-04]. https://doi.org/10.3389/fneur.2019.00568. [32] ZUCCOLI G,PIPITONE N,HALDIPUR A,et al. Imaging findings in primary central nervous system vasculitis[J/OL]. Clin Exp Rheumatol,2011,29(1 Suppl 64):S104-S109[2021-12-04]. https://pubmed.ncbi.nlm.nih.gov/21586204/. [33] DE BOYSSON H,ZUBER M,NAGGARA O,et al. Primary angiitis of the central nervous system:description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system[J]. Arthritis Rheumatol,2014,66(5):1315-1326. [34] SALVARANI C,BROWN R D JR,CALAMIA K T,et al. Primary central nervous system vasculitis:analysis of 101 patients[J]. Ann Neurol,2007,62(5):442-451. [35] MARCOLINI E,HINE J. Approach to the diagnosis and management of subarachnoid hemorrhage[J]. West J Emerg Med,2019,20(2):203-211. [36] DE OLIVEIRA MANOEL A L,MANSUR A,MURPHY A,et al. Aneurysmal subarachnoid haemorrhage from a neuroimaging perspective[J/OL]. Crit Care,2014,18(6):557[2021-12-04]. https://doi.org/10.1186/s13054-014-0557-2. [37] ZUURBIER S M,MIDDELDORP S,STAM J,et al. Sex differences in cerebral venous thrombosis:a systematic analysis of a shift over time[J]. Int J Stroke,2016,11(2):164-170. [38] LUO Y X,TIAN X,WANG X F. Diagnosis and treatment of cerebral venous thrombosis:a review[J/OL]. Front Aging Neurosci,2018,10:2[2021-12-04]. https://doi.org/10.3389/fnagi.2018.00002. [39] 冯子凌. 颅内静脉系统血栓形成的临床诊疗分析[J]. 中国药物与临床,2018,18(11):1966-1968. [40] VAN OS H J,MULDER I A,VAN DER SCHAAF I C,et al. Role of atherosclerosis,clot extent,and penumbra volume in headache during ischemic stroke[J]. Neurology,2016,87(11):1124-1130. [41] HARRIOTT A M,KARAKAYA F,AYATA C. Headache after ischemic stroke:a systematic review and meta-analysis[J/OL]. Neurology,2020,94(1):e75-e86[2021-12-04]. https://doi.org/10.1212/WNL.0000000000008591. [42] C HO S,LEE M J,C H U NG C S. Ef fe c t of nimodipine treatment on the clinical course of reversible cerebral vasoconstriction syndrome[J/OL]. Front Neurol,2019,10:644[2021-12-04]. https://doi.org/10.3389/fneur.2019.00644. [43] ROZEN T D,BEAMS J L. New daily persistent headache with a thunderclap headache onset and complete response to nimodipine(a new distinct subtype of NDPH)[J/OL]. J Headache Pain,2013,14(1):100[2021-12-04]. https://doi.org/10.1186/1129-2377-14-100. [44] MIJALSKI C,DAKAY K,MILLER-PATTERSON C,et al. Magnesium for treatment of reversible cerebral vasoconstriction syndrome:case series[J]. Neurohospitalist,2016,6(3):111-113. [45] SONG J K,FISHER S,SEIFERT T D,et al. Postpartum cerebral angiopathy:atypical features and treatment with intracranial balloon angioplasty[J]. Neuroradiology,2004,46(12):1022-1026. [46] BOUCHARD M,VERREAULT S,GARIÉPY J L,et al. Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome[J]. Headache,2009,49(1):142-145. [47] GRÄNDE P O,LUNDGREN A,BJARTMARZ H,et al. Segmental cerebral vasoconstriction:successful treatment of secondary cerebral ischaemia with intravenous prostacyclin[J]. Cephalalgia,2010,30(7):890-895. [48] DUCROS A. Le syndrome de vasoconstriction cérébrale réversible[ Reversible cerebral vasoconstriction syndrome][J]. Rev Neurol(Paris),2010,166(4):365-376. |
[1] |
Chinese Stroke Association Headache Society, Headache Group of Chinese Society of Neurology.
Chinese Expert Consensus on the Standardization Construction of Headache Outpatient [J]. Chinese Journal of Stroke, 2024, 19(7): 822-832. |
[2] | LEI Zhen, ZHANG Huan, WU Songdi. Research Advances in Animal Models of Central Retinal Artery Occlusion [J]. Chinese Journal of Stroke, 2024, 19(3): 266-272. |
[3] | FU Shuhao, XIAO Yiqin, HAN Xiang, YANG Shilin. Giant Cell Arteritis Manifests as Posterior Ischemic Optic Neuropathy: A Case Report [J]. Chinese Journal of Stroke, 2024, 19(3): 288-292. |
[4] | ZHAO Mengqiu, KUANG Shenyi, ZHANG Shufan, HAN Xiang, YANG Shilin. A Case Report of Central Retinal Artery Occlusion Caused by Internal Carotid Artery Dissection [J]. Chinese Journal of Stroke, 2024, 19(11): 1296-1300. |
[5] |
LIU Chenglong, ZHANG Qian, ZHAO Jizong.
Progress of Pathogenesis of Hyperthyroidism Complicated with Moyamoya Disease
[J]. Chinese Journal of Stroke, 2023, 18(03): 353-358.
|
[6] | XU Luyao, CHEN Xiaodi, LIANG Zhigang. Advances in Imaging Evaluation of Post-stroke Aphasia [J]. Chinese Journal of Stroke, 2022, 17(09): 1017-1021. |
[7] | LU Jiajie, ZHAO Hongru. Headache Phenotypes and Possible Mechanisms of Dural Arteriovenous Fistula [J]. Chinese Journal of Stroke, 2022, 17(05): 461-465. |
[8] | DING Man, XIAO Zheman. Central Nervous System Vasculitis and Headache [J]. Chinese Journal of Stroke, 2022, 17(05): 466-471. |
[9] | DENG Ziru, SUN Wen, CHEN Yuhua, LYU Xinyi, GUI Wei. Progress of Headache Attributed to Unruptured Intracranial Saccular Aneurysm [J]. Chinese Journal of Stroke, 2022, 17(05): 472-476. |
[10] | CHEN Meijiao, JIN Haidi, LIU Kaiming. Headache Characteristics of Carotid Artery Dissection [J]. Chinese Journal of Stroke, 2022, 17(05): 477-482. |
[11] | WANG Aimin, WANG Xianling. Progress in the Pathogenesis of Post-stroke of Emotional Instability [J]. Chinese Journal of Stroke, 2021, 16(12): 1284-1289. |
[12] | CHEN Shuang-Shuang, ZHOU Yi-Lun. Progress on the Relationship between Albuminuria and Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(06): 625-630. |
[13] | LU Hao-Xuan, MA Xiao-Xiao, LOU Xin. Progress of Hyperuricemia Related Cerebrovascular Diseases [J]. Chinese Journal of Stroke, 2021, 16(05): 524-528. |
[14] | YANG Qi-Zhou, FU Rui, WANG Li-li. Pathogenesis of Cancer-Associated Ischemic Stroke [J]. Chinese Journal of Stroke, 2021, 16(02): 124-129. |
[15] | XU Li, YUAN Dan, GONG Zhong, WANG Ying-Peng, LI Dong-Hua, WANG Hai-Peng. Headache Characteristics of Cerebral Venous Thrombosis Patients with Headache as the Sole Presentation [J]. Chinese Journal of Stroke, 2020, 15(12): 1313-1316. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||